CLINICAL VARIABLES FOR PREDICTING METASTATIC RENAL CELL CARCINOMA PATIENTS WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY

被引：0
|
作者：
Ohno, Yoshio
Nakashima, Jun
Ohori, Makoto
Hashimoto, Takeshi
Gondo, Tatsuo
Okubo, Hideki
Shimodaira, Kenji
Tachibana, Masaaki
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.2161
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1999
引用
收藏
页码：E806 / E807
页数：3
相关论文
共 50 条
  • [1] Clinical variables for predicting stage IV renal cell carcinoma patients who will not benefit from cytoreductive nephrectomy
    Ohno, Y.
    Nakashima, J.
    Ohori, M.
    Okubo, H.
    Shimodaira, K.
    Sawada, Y.
    Tachibana, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E1020 - U134
  • [2] IDENTIFYING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY
    Culp, Stephen H.
    Abel, E. Jason
    Margulis, Vitaly
    Bill, Kate Lynn
    Tamboli, Pheroze
    Jonasch, Eric
    Matin, Surena F.
    Swanson, David A.
    Tannir, Nizar M.
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 498 - 498
  • [3] Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status
    Ohno, Yoshio
    Nakashima, Jun
    Ohori, Makoto
    Tanaka, Ayako
    Hashimoto, Takeshi
    Gondo, Tatsuo
    Hatano, Tadashi
    Tachibana, Masaaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 139 - 145
  • [4] Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status
    Yoshio Ohno
    Jun Nakashima
    Makoto Ohori
    Ayako Tanaka
    Takeshi Hashimoto
    Tatsuo Gondo
    Tadashi Hatano
    Masaaki Tachibana
    International Journal of Clinical Oncology, 2014, 19 : 139 - 145
  • [5] Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Lee, Jae-Lyun
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 96 - 102
  • [6] Cytoreductive nephrectomy for metastatic renal cell carcinoma
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (04) : 270 - 271
  • [7] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Mattigk, Angelika
    Zengerling, Friedemann
    UROLOGIE, 2024, 63 (11): : 1151 - 1154
  • [8] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Margulis, Vitaly
    Matin, Surena F.
    Wood, Christopher G.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 474 - 480
  • [9] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Chery, Lisly J.
    Karam, Jose A.
    Wood, Christopher G.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (09) : 696 - 703
  • [10] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Healy, Kelly A.
    Marshall, Fray F.
    Ogan, Kenneth
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1295 - 1304
12345